FDA expands Addyi approval for postmenopausal women


FDA expands Addyi approval for postmenopausal women

Reading

Read this text and listen to it at the same time. If you don’t know a word click it to see explanation, hear pronunciation or add it to vocabulary.
FDA expands Addyi approval for postmenopausal women

US health officials expanded approval for a drug called Addyi. It can now help postmenopausal women up to 65 years old.

Addyi was first approved for women before menopause 10 years ago. It has side effects like dizziness and a warning about alcohol.

Low sexual desire is a recognized medical problem for many women. Doctors must check many other issues before giving this medicine.

The FDA rejected Addyi twice before approving it in 2015. A group worked hard to get the drug approved for women.

Sales of Addyi were lower than expected by many people. Another drug for low female libido came out in 2019.


Questions

Answer the questions to the text. Speak or write, you choose. AI will assess your answers.

What is the name of the drug that helps postmenopausal women?

The drug is called Addyi.

How long ago was Addyi first approved?

Addyi was first approved 10 years ago.

What must doctors check before giving Addyi to patients?

Doctors must check many other issues before giving this medicine.


Describe the article image

Look at the article image and describe what you see on it. You may either speak or write your answer there.


Discussion

Discuss this article with your AI tutor to practice. Your tutor will help you with vocabulary and grammar.

Read a new article every day and
discuss it with AI at lingolette.com
All content and tasks are generated by AI inspired by a real publication.
FDA expands Addyi approval for postmenopausal women